agilon health, inc. Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- agilon health, inc. shares issued, shares, share-based payment arrangement, after forfeiture for the quarter ending 2023-03-31 was 2.10M shares, a 62.50% decline year-over-year.
- agilon health, inc. shares issued, shares, share-based payment arrangement, after forfeiture for the quarter ending 2022-12-31 was 700.00K shares, a 91.85% decline year-over-year.
- agilon health, inc. shares issued, shares, share-based payment arrangement, after forfeiture for the quarter ending 2022-09-30 was 3.50M shares, a 426.32% increase year-over-year.
- agilon health, inc. shares issued, shares, share-based payment arrangement, after forfeiture for the quarter ending 2022-06-30 was 2.50M shares.
- agilon health, inc. shares issued, shares, share-based payment arrangement, after forfeiture for fiscal 2024 was 3.80M shares, a 5.56% increase from fiscal 2023.
- agilon health, inc. shares issued, shares, share-based payment arrangement, after forfeiture for fiscal 2023 was 3.60M shares, a 70.73% decline from fiscal 2022.
- agilon health, inc. shares issued, shares, share-based payment arrangement, after forfeiture for fiscal 2022 was 12.30M shares, a 32.26% increase from fiscal 2021.
- agilon health, inc. shares issued, shares, share-based payment arrangement, after forfeiture for fiscal 2021 was 9.30M shares, a 304.35% increase from fiscal 2020.
| Period end | Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture 3 month | Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture 12 month |
|---|---|---|
| 2024-12-31 | 3.80M shares 10-K · filed 2026-02-25 | |
| 2023-12-31 | 3.60M shares 10-K · filed 2026-02-25 | |
| 2023-03-31 | 2.10M shares 10-Q · filed 2023-05-09 | 8.80M shares derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | 700.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | 12.30M shares 10-K · filed 2025-02-25 |
| 2022-09-30 | 3.50M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 20.19M shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-06-30 | 2.50M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 17.35M shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-03-31 | 5.60M shares 10-Q · filed 2023-05-09 | 14.80M shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | 8.59M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 9.30M shares 10-K · filed 2023-03-01 |
| 2021-09-30 | 665.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | |
| 2021-06-30 | -54.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | |
| 2021-03-31 | 100.00K shares 10-Q · filed 2022-05-05 | |
| 2020-12-31 | 2.30M shares 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |